nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—CYP2A6—Fluorouracil—head and neck cancer	0.136	0.506	CbGbCtD
Sevoflurane—ALB—Fluorouracil—head and neck cancer	0.0867	0.323	CbGbCtD
Sevoflurane—CYP3A4—Vinblastine—head and neck cancer	0.0252	0.0938	CbGbCtD
Sevoflurane—CYP3A4—Docetaxel—head and neck cancer	0.0208	0.0773	CbGbCtD
Sevoflurane—ND1—exocrine gland—head and neck cancer	0.0162	0.0524	CbGeAlD
Sevoflurane—ATP2C1—hair follicle—head and neck cancer	0.0123	0.0397	CbGeAlD
Sevoflurane—ND1—mouth—head and neck cancer	0.0121	0.0391	CbGeAlD
Sevoflurane—ND1—neck—head and neck cancer	0.0104	0.0335	CbGeAlD
Sevoflurane—GABRP—mouth—head and neck cancer	0.00946	0.0305	CbGeAlD
Sevoflurane—GABRE—hair follicle—head and neck cancer	0.00921	0.0297	CbGeAlD
Sevoflurane—GABRA3—neck—head and neck cancer	0.00836	0.027	CbGeAlD
Sevoflurane—ND1—saliva-secreting gland—head and neck cancer	0.00809	0.0261	CbGeAlD
Sevoflurane—KCNK2—thyroid gland—head and neck cancer	0.00738	0.0238	CbGeAlD
Sevoflurane—KCNK10—head—head and neck cancer	0.007	0.0226	CbGeAlD
Sevoflurane—KCNK9—head—head and neck cancer	0.00696	0.0225	CbGeAlD
Sevoflurane—ATP5D—parotid gland—head and neck cancer	0.00681	0.022	CbGeAlD
Sevoflurane—ATP2C1—parotid gland—head and neck cancer	0.00672	0.0217	CbGeAlD
Sevoflurane—ATP5D—saliva-secreting gland—head and neck cancer	0.00652	0.021	CbGeAlD
Sevoflurane—ATP2C1—saliva-secreting gland—head and neck cancer	0.00644	0.0208	CbGeAlD
Sevoflurane—Hepatic failure—Hydroxyurea—head and neck cancer	0.00637	0.0203	CcSEcCtD
Sevoflurane—KCNK3—head—head and neck cancer	0.00632	0.0204	CbGeAlD
Sevoflurane—Renal failure acute—Hydroxyurea—head and neck cancer	0.0062	0.0197	CcSEcCtD
Sevoflurane—Leukocytosis—Fluorouracil—head and neck cancer	0.00604	0.0192	CcSEcCtD
Sevoflurane—ATP5D—connective tissue—head and neck cancer	0.00599	0.0193	CbGeAlD
Sevoflurane—GABRQ—head—head and neck cancer	0.00563	0.0182	CbGeAlD
Sevoflurane—Dermatitis contact—Fluorouracil—head and neck cancer	0.00561	0.0179	CcSEcCtD
Sevoflurane—KCNA1—thyroid gland—head and neck cancer	0.00561	0.0181	CbGeAlD
Sevoflurane—ND1—lymphoid tissue—head and neck cancer	0.00544	0.0175	CbGeAlD
Sevoflurane—GRIA1—head—head and neck cancer	0.00509	0.0164	CbGeAlD
Sevoflurane—ATP5D—trachea—head and neck cancer	0.00503	0.0162	CbGeAlD
Sevoflurane—KCNA1—head—head and neck cancer	0.00497	0.016	CbGeAlD
Sevoflurane—ATP2C1—trachea—head and neck cancer	0.00497	0.016	CbGeAlD
Sevoflurane—ND1—thyroid gland—head and neck cancer	0.00494	0.0159	CbGeAlD
Sevoflurane—GABRG3—head—head and neck cancer	0.00493	0.0159	CbGeAlD
Sevoflurane—GABRP—trachea—head and neck cancer	0.00487	0.0157	CbGeAlD
Sevoflurane—Pancreatitis—Hydroxyurea—head and neck cancer	0.00485	0.0154	CcSEcCtD
Sevoflurane—Chest discomfort—Docetaxel—head and neck cancer	0.00463	0.0147	CcSEcCtD
Sevoflurane—Dysuria—Hydroxyurea—head and neck cancer	0.00463	0.0147	CcSEcCtD
Sevoflurane—KCNK2—lymph node—head and neck cancer	0.00458	0.0148	CbGeAlD
Sevoflurane—Bone disorder—Docetaxel—head and neck cancer	0.00454	0.0144	CcSEcCtD
Sevoflurane—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.00451	0.0143	CcSEcCtD
Sevoflurane—Oliguria—Docetaxel—head and neck cancer	0.00445	0.0142	CcSEcCtD
Sevoflurane—ND1—head—head and neck cancer	0.00438	0.0141	CbGeAlD
Sevoflurane—Haemoglobin—Vinblastine—head and neck cancer	0.00436	0.0139	CcSEcCtD
Sevoflurane—Haemorrhage—Vinblastine—head and neck cancer	0.00434	0.0138	CcSEcCtD
Sevoflurane—ATP2C1—lymphoid tissue—head and neck cancer	0.00433	0.014	CbGeAlD
Sevoflurane—Pharyngitis—Vinblastine—head and neck cancer	0.00431	0.0137	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00417	0.0133	CcSEcCtD
Sevoflurane—Respiratory failure—Docetaxel—head and neck cancer	0.00417	0.0133	CcSEcCtD
Sevoflurane—GABRD—head—head and neck cancer	0.00409	0.0132	CbGeAlD
Sevoflurane—GABRA3—thyroid gland—head and neck cancer	0.00398	0.0128	CbGeAlD
Sevoflurane—ATP5D—thyroid gland—head and neck cancer	0.00398	0.0128	CbGeAlD
Sevoflurane—Haemoglobin—Hydroxyurea—head and neck cancer	0.00398	0.0127	CcSEcCtD
Sevoflurane—Haemorrhage—Hydroxyurea—head and neck cancer	0.00396	0.0126	CcSEcCtD
Sevoflurane—GABRG1—head—head and neck cancer	0.00393	0.0127	CbGeAlD
Sevoflurane—ATP2C1—thyroid gland—head and neck cancer	0.00393	0.0127	CbGeAlD
Sevoflurane—Cardiac arrest—Fluorouracil—head and neck cancer	0.00392	0.0125	CcSEcCtD
Sevoflurane—GABRA6—head—head and neck cancer	0.00391	0.0126	CbGeAlD
Sevoflurane—GABRB1—head—head and neck cancer	0.00381	0.0123	CbGeAlD
Sevoflurane—GABRA5—head—head and neck cancer	0.00379	0.0122	CbGeAlD
Sevoflurane—GABRB3—connective tissue—head and neck cancer	0.00375	0.0121	CbGeAlD
Sevoflurane—GABRE—trachea—head and neck cancer	0.00372	0.012	CbGeAlD
Sevoflurane—Angiopathy—Hydroxyurea—head and neck cancer	0.00359	0.0114	CcSEcCtD
Sevoflurane—Chills—Hydroxyurea—head and neck cancer	0.00355	0.0113	CcSEcCtD
Sevoflurane—GABRA3—head—head and neck cancer	0.00353	0.0114	CbGeAlD
Sevoflurane—ATP5D—head—head and neck cancer	0.00353	0.0114	CbGeAlD
Sevoflurane—ATP2C1—head—head and neck cancer	0.00349	0.0112	CbGeAlD
Sevoflurane—GABRA4—head—head and neck cancer	0.00344	0.0111	CbGeAlD
Sevoflurane—GABRP—head—head and neck cancer	0.00342	0.011	CbGeAlD
Sevoflurane—Hepatic failure—Docetaxel—head and neck cancer	0.00331	0.0105	CcSEcCtD
Sevoflurane—Convulsion—Vinblastine—head and neck cancer	0.00328	0.0104	CcSEcCtD
Sevoflurane—Hypertension—Vinblastine—head and neck cancer	0.00326	0.0104	CcSEcCtD
Sevoflurane—Atrial fibrillation—Docetaxel—head and neck cancer	0.00314	0.00999	CcSEcCtD
Sevoflurane—Conjunctivitis—Fluorouracil—head and neck cancer	0.00309	0.00982	CcSEcCtD
Sevoflurane—ND1—lymph node—head and neck cancer	0.00307	0.0099	CbGeAlD
Sevoflurane—Thrombocytopenia—Vinblastine—head and neck cancer	0.00302	0.00962	CcSEcCtD
Sevoflurane—Convulsion—Hydroxyurea—head and neck cancer	0.00299	0.00951	CcSEcCtD
Sevoflurane—GABRE—thyroid gland—head and neck cancer	0.00294	0.00948	CbGeAlD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00291	0.00928	CcSEcCtD
Sevoflurane—GABRB2—head—head and neck cancer	0.00288	0.00929	CbGeAlD
Sevoflurane—GABRG2—head—head and neck cancer	0.00288	0.00929	CbGeAlD
Sevoflurane—Haemoglobin—Fluorouracil—head and neck cancer	0.00287	0.00912	CcSEcCtD
Sevoflurane—Haemorrhage—Fluorouracil—head and neck cancer	0.00285	0.00907	CcSEcCtD
Sevoflurane—Pharyngitis—Fluorouracil—head and neck cancer	0.00283	0.00901	CcSEcCtD
Sevoflurane—Oedema—Hydroxyurea—head and neck cancer	0.00281	0.00896	CcSEcCtD
Sevoflurane—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00276	0.00878	CcSEcCtD
Sevoflurane—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00275	0.00877	CcSEcCtD
Sevoflurane—Liver function test abnormal—Docetaxel—head and neck cancer	0.00275	0.00874	CcSEcCtD
Sevoflurane—Skin disorder—Hydroxyurea—head and neck cancer	0.00273	0.0087	CcSEcCtD
Sevoflurane—Pain—Vinblastine—head and neck cancer	0.00264	0.0084	CcSEcCtD
Sevoflurane—GABRA2—head—head and neck cancer	0.00263	0.00849	CbGeAlD
Sevoflurane—GABRE—head—head and neck cancer	0.00261	0.00841	CbGeAlD
Sevoflurane—Arrhythmia—Fluorouracil—head and neck cancer	0.00255	0.00811	CcSEcCtD
Sevoflurane—Feeling abnormal—Vinblastine—head and neck cancer	0.00254	0.00809	CcSEcCtD
Sevoflurane—GABRA1—head—head and neck cancer	0.00254	0.0082	CbGeAlD
Sevoflurane—Bronchospasm—Docetaxel—head and neck cancer	0.00253	0.00805	CcSEcCtD
Sevoflurane—Dyspnoea—Hydroxyurea—head and neck cancer	0.00251	0.00798	CcSEcCtD
Sevoflurane—Somnolence—Hydroxyurea—head and neck cancer	0.0025	0.00796	CcSEcCtD
Sevoflurane—GABRB3—thyroid gland—head and neck cancer	0.00249	0.00804	CbGeAlD
Sevoflurane—ATP5D—lymph node—head and neck cancer	0.00247	0.00798	CbGeAlD
Sevoflurane—ATP2C1—lymph node—head and neck cancer	0.00244	0.00787	CbGeAlD
Sevoflurane—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00243	0.00773	CcSEcCtD
Sevoflurane—Pain—Hydroxyurea—head and neck cancer	0.00241	0.00766	CcSEcCtD
Sevoflurane—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00232	0.00738	CcSEcCtD
Sevoflurane—Hypersensitivity—Vinblastine—head and neck cancer	0.00227	0.00724	CcSEcCtD
Sevoflurane—Renal failure—Docetaxel—head and neck cancer	0.00225	0.00717	CcSEcCtD
Sevoflurane—Jaundice—Docetaxel—head and neck cancer	0.00223	0.00711	CcSEcCtD
Sevoflurane—Conjunctivitis—Docetaxel—head and neck cancer	0.00223	0.00709	CcSEcCtD
Sevoflurane—Body temperature increased—Hydroxyurea—head and neck cancer	0.00222	0.00708	CcSEcCtD
Sevoflurane—Asthenia—Vinblastine—head and neck cancer	0.00221	0.00705	CcSEcCtD
Sevoflurane—GABRB3—head—head and neck cancer	0.00221	0.00713	CbGeAlD
Sevoflurane—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00217	0.0069	CcSEcCtD
Sevoflurane—Convulsion—Fluorouracil—head and neck cancer	0.00215	0.00684	CcSEcCtD
Sevoflurane—Chest pain—Fluorouracil—head and neck cancer	0.00211	0.00672	CcSEcCtD
Sevoflurane—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00207	0.0066	CcSEcCtD
Sevoflurane—Haemoglobin—Docetaxel—head and neck cancer	0.00207	0.00658	CcSEcCtD
Sevoflurane—Haemorrhage—Docetaxel—head and neck cancer	0.00206	0.00655	CcSEcCtD
Sevoflurane—Hepatitis—Docetaxel—head and neck cancer	0.00206	0.00655	CcSEcCtD
Sevoflurane—Confusional state—Fluorouracil—head and neck cancer	0.00204	0.0065	CcSEcCtD
Sevoflurane—Pharyngitis—Docetaxel—head and neck cancer	0.00204	0.0065	CcSEcCtD
Sevoflurane—Dizziness—Vinblastine—head and neck cancer	0.00204	0.00649	CcSEcCtD
Sevoflurane—Urinary tract disorder—Docetaxel—head and neck cancer	0.00203	0.00647	CcSEcCtD
Sevoflurane—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00203	0.00645	CcSEcCtD
Sevoflurane—Oedema—Fluorouracil—head and neck cancer	0.00203	0.00645	CcSEcCtD
Sevoflurane—Asthenia—Hydroxyurea—head and neck cancer	0.00202	0.00643	CcSEcCtD
Sevoflurane—Urethral disorder—Docetaxel—head and neck cancer	0.00202	0.00642	CcSEcCtD
Sevoflurane—Nervous system disorder—Fluorouracil—head and neck cancer	0.00199	0.00632	CcSEcCtD
Sevoflurane—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00198	0.00631	CcSEcCtD
Sevoflurane—Tachycardia—Fluorouracil—head and neck cancer	0.00198	0.00629	CcSEcCtD
Sevoflurane—Vomiting—Vinblastine—head and neck cancer	0.00196	0.00624	CcSEcCtD
Sevoflurane—Headache—Vinblastine—head and neck cancer	0.00193	0.00615	CcSEcCtD
Sevoflurane—Cardiac disorder—Docetaxel—head and neck cancer	0.00191	0.00608	CcSEcCtD
Sevoflurane—Hypotension—Fluorouracil—head and neck cancer	0.00189	0.00602	CcSEcCtD
Sevoflurane—Angiopathy—Docetaxel—head and neck cancer	0.00187	0.00594	CcSEcCtD
Sevoflurane—Dizziness—Hydroxyurea—head and neck cancer	0.00186	0.00592	CcSEcCtD
Sevoflurane—CYP2B6—lymphoid tissue—head and neck cancer	0.00186	0.006	CbGeAlD
Sevoflurane—Immune system disorder—Docetaxel—head and neck cancer	0.00186	0.00592	CcSEcCtD
Sevoflurane—Mediastinal disorder—Docetaxel—head and neck cancer	0.00185	0.0059	CcSEcCtD
Sevoflurane—Chills—Docetaxel—head and neck cancer	0.00185	0.00588	CcSEcCtD
Sevoflurane—GABRA2—lymph node—head and neck cancer	0.00184	0.00594	CbGeAlD
Sevoflurane—Arrhythmia—Docetaxel—head and neck cancer	0.00184	0.00585	CcSEcCtD
Sevoflurane—Nausea—Vinblastine—head and neck cancer	0.00183	0.00583	CcSEcCtD
Sevoflurane—Insomnia—Fluorouracil—head and neck cancer	0.00183	0.00583	CcSEcCtD
Sevoflurane—GABRE—lymph node—head and neck cancer	0.00183	0.00589	CbGeAlD
Sevoflurane—Dyspnoea—Fluorouracil—head and neck cancer	0.00181	0.00575	CcSEcCtD
Sevoflurane—Mental disorder—Docetaxel—head and neck cancer	0.0018	0.00574	CcSEcCtD
Sevoflurane—Somnolence—Fluorouracil—head and neck cancer	0.0018	0.00573	CcSEcCtD
Sevoflurane—Malnutrition—Docetaxel—head and neck cancer	0.00179	0.0057	CcSEcCtD
Sevoflurane—Vomiting—Hydroxyurea—head and neck cancer	0.00179	0.00569	CcSEcCtD
Sevoflurane—Rash—Hydroxyurea—head and neck cancer	0.00177	0.00565	CcSEcCtD
Sevoflurane—Dermatitis—Hydroxyurea—head and neck cancer	0.00177	0.00564	CcSEcCtD
Sevoflurane—Headache—Hydroxyurea—head and neck cancer	0.00176	0.00561	CcSEcCtD
Sevoflurane—Dysgeusia—Docetaxel—head and neck cancer	0.00175	0.00558	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00175	0.00557	CcSEcCtD
Sevoflurane—CYP2E1—lymphoid tissue—head and neck cancer	0.00175	0.00563	CbGeAlD
Sevoflurane—Pain—Fluorouracil—head and neck cancer	0.00173	0.00551	CcSEcCtD
Sevoflurane—Nausea—Hydroxyurea—head and neck cancer	0.00167	0.00532	CcSEcCtD
Sevoflurane—Feeling abnormal—Fluorouracil—head and neck cancer	0.00167	0.00531	CcSEcCtD
Sevoflurane—ALB—lymph node—head and neck cancer	0.00166	0.00537	CbGeAlD
Sevoflurane—Urticaria—Fluorouracil—head and neck cancer	0.00161	0.00512	CcSEcCtD
Sevoflurane—Syncope—Docetaxel—head and neck cancer	0.00161	0.00511	CcSEcCtD
Sevoflurane—Body temperature increased—Fluorouracil—head and neck cancer	0.0016	0.0051	CcSEcCtD
Sevoflurane—CYP2E1—thyroid gland—head and neck cancer	0.00159	0.00511	CbGeAlD
Sevoflurane—Loss of consciousness—Docetaxel—head and neck cancer	0.00157	0.00501	CcSEcCtD
Sevoflurane—Cough—Docetaxel—head and neck cancer	0.00156	0.00497	CcSEcCtD
Sevoflurane—Convulsion—Docetaxel—head and neck cancer	0.00155	0.00494	CcSEcCtD
Sevoflurane—Hypertension—Docetaxel—head and neck cancer	0.00155	0.00492	CcSEcCtD
Sevoflurane—Chest pain—Docetaxel—head and neck cancer	0.00152	0.00485	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00151	0.00482	CcSEcCtD
Sevoflurane—CYP2B6—head—head and neck cancer	0.0015	0.00484	CbGeAlD
Sevoflurane—Hypersensitivity—Fluorouracil—head and neck cancer	0.00149	0.00475	CcSEcCtD
Sevoflurane—Dry mouth—Docetaxel—head and neck cancer	0.00149	0.00475	CcSEcCtD
Sevoflurane—Confusional state—Docetaxel—head and neck cancer	0.00147	0.00469	CcSEcCtD
Sevoflurane—Oedema—Docetaxel—head and neck cancer	0.00146	0.00465	CcSEcCtD
Sevoflurane—Anaphylactic shock—Docetaxel—head and neck cancer	0.00146	0.00465	CcSEcCtD
Sevoflurane—Shock—Docetaxel—head and neck cancer	0.00144	0.00458	CcSEcCtD
Sevoflurane—Nervous system disorder—Docetaxel—head and neck cancer	0.00143	0.00456	CcSEcCtD
Sevoflurane—Pruritus—Fluorouracil—head and neck cancer	0.00143	0.00456	CcSEcCtD
Sevoflurane—Thrombocytopenia—Docetaxel—head and neck cancer	0.00143	0.00456	CcSEcCtD
Sevoflurane—Tachycardia—Docetaxel—head and neck cancer	0.00143	0.00454	CcSEcCtD
Sevoflurane—Skin disorder—Docetaxel—head and neck cancer	0.00142	0.00452	CcSEcCtD
Sevoflurane—CYP2E1—head—head and neck cancer	0.00141	0.00454	CbGeAlD
Sevoflurane—Hypotension—Docetaxel—head and neck cancer	0.00137	0.00435	CcSEcCtD
Sevoflurane—Dizziness—Fluorouracil—head and neck cancer	0.00134	0.00426	CcSEcCtD
Sevoflurane—Insomnia—Docetaxel—head and neck cancer	0.00132	0.00421	CcSEcCtD
Sevoflurane—Dyspnoea—Docetaxel—head and neck cancer	0.0013	0.00415	CcSEcCtD
Sevoflurane—Somnolence—Docetaxel—head and neck cancer	0.0013	0.00414	CcSEcCtD
Sevoflurane—Vomiting—Fluorouracil—head and neck cancer	0.00129	0.0041	CcSEcCtD
Sevoflurane—Rash—Fluorouracil—head and neck cancer	0.00128	0.00406	CcSEcCtD
Sevoflurane—Dermatitis—Fluorouracil—head and neck cancer	0.00128	0.00406	CcSEcCtD
Sevoflurane—Headache—Fluorouracil—head and neck cancer	0.00127	0.00404	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00126	0.00402	CcSEcCtD
Sevoflurane—Pain—Docetaxel—head and neck cancer	0.00125	0.00398	CcSEcCtD
Sevoflurane—Feeling abnormal—Docetaxel—head and neck cancer	0.0012	0.00383	CcSEcCtD
Sevoflurane—Nausea—Fluorouracil—head and neck cancer	0.0012	0.00383	CcSEcCtD
Sevoflurane—Body temperature increased—Docetaxel—head and neck cancer	0.00116	0.00368	CcSEcCtD
Sevoflurane—Hypersensitivity—Docetaxel—head and neck cancer	0.00108	0.00343	CcSEcCtD
Sevoflurane—Asthenia—Docetaxel—head and neck cancer	0.00105	0.00334	CcSEcCtD
Sevoflurane—Pruritus—Docetaxel—head and neck cancer	0.00103	0.00329	CcSEcCtD
Sevoflurane—Dizziness—Docetaxel—head and neck cancer	0.000967	0.00308	CcSEcCtD
Sevoflurane—Vomiting—Docetaxel—head and neck cancer	0.000929	0.00296	CcSEcCtD
Sevoflurane—Rash—Docetaxel—head and neck cancer	0.000922	0.00293	CcSEcCtD
Sevoflurane—Dermatitis—Docetaxel—head and neck cancer	0.000921	0.00293	CcSEcCtD
Sevoflurane—Headache—Docetaxel—head and neck cancer	0.000916	0.00291	CcSEcCtD
Sevoflurane—Nausea—Docetaxel—head and neck cancer	0.000868	0.00276	CcSEcCtD
Sevoflurane—CYP2E1—Biological oxidations—NAT2—head and neck cancer	0.000388	0.00361	CbGpPWpGaD
Sevoflurane—CYP2E1—Metapathway biotransformation—NAT2—head and neck cancer	0.000382	0.00356	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000372	0.00347	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000368	0.00343	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—SOD2—head and neck cancer	0.000355	0.00331	CbGpPWpGaD
Sevoflurane—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000349	0.00325	CbGpPWpGaD
Sevoflurane—KCNK18—Neuronal System—MAPK1—head and neck cancer	0.000348	0.00324	CbGpPWpGaD
Sevoflurane—GRIA1—BDNF signaling pathway—STAT3—head and neck cancer	0.000347	0.00323	CbGpPWpGaD
Sevoflurane—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000342	0.00318	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—GPX1—head and neck cancer	0.000339	0.00316	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000336	0.00313	CbGpPWpGaD
Sevoflurane—GRIA1—BDNF signaling pathway—MAPK3—head and neck cancer	0.000331	0.00309	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000327	0.00304	CbGpPWpGaD
Sevoflurane—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000322	0.00301	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000321	0.00299	CbGpPWpGaD
Sevoflurane—GRIA1—BDNF signaling pathway—MAPK1—head and neck cancer	0.000315	0.00294	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000315	0.00294	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000313	0.00292	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—NAT2—head and neck cancer	0.000313	0.00291	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—NAT2—head and neck cancer	0.000313	0.00291	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000307	0.00287	CbGpPWpGaD
Sevoflurane—CYP2A6—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000304	0.00284	CbGpPWpGaD
Sevoflurane—KCNK10—Neuronal System—MAPK1—head and neck cancer	0.000284	0.00264	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000282	0.00263	CbGpPWpGaD
Sevoflurane—KCNK18—Neuronal System—HRAS—head and neck cancer	0.000279	0.0026	CbGpPWpGaD
Sevoflurane—CYP2A6—NRF2 pathway—GSTM1—head and neck cancer	0.000276	0.00257	CbGpPWpGaD
Sevoflurane—KCNA1—Neuronal System—MAPK1—head and neck cancer	0.000275	0.00256	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—DPYD—head and neck cancer	0.000274	0.00256	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—DPYD—head and neck cancer	0.000274	0.00256	CbGpPWpGaD
Sevoflurane—KCNK2—Neuronal System—MAPK1—head and neck cancer	0.000271	0.00253	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000269	0.00251	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000269	0.00251	CbGpPWpGaD
Sevoflurane—KCNK3—Neuronal System—MAPK1—head and neck cancer	0.000264	0.00246	CbGpPWpGaD
Sevoflurane—KCNK9—Neuronal System—MAPK1—head and neck cancer	0.000264	0.00246	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—YAP1—head and neck cancer	0.00026	0.00243	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—YAP1—head and neck cancer	0.00026	0.00243	CbGpPWpGaD
Sevoflurane—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000259	0.00241	CbGpPWpGaD
Sevoflurane—GRIA1—BDNF signaling pathway—HRAS—head and neck cancer	0.000253	0.00236	CbGpPWpGaD
Sevoflurane—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000244	0.00228	CbGpPWpGaD
Sevoflurane—GRIA1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000242	0.00226	CbGpPWpGaD
Sevoflurane—CYP2A6—Biological oxidations—GSTM1—head and neck cancer	0.000242	0.00226	CbGpPWpGaD
Sevoflurane—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000242	0.00225	CbGpPWpGaD
Sevoflurane—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000232	0.00216	CbGpPWpGaD
Sevoflurane—CYP2A6—Biological oxidations—CYP1A1—head and neck cancer	0.00023	0.00214	CbGpPWpGaD
Sevoflurane—KCNK10—Neuronal System—HRAS—head and neck cancer	0.000228	0.00212	CbGpPWpGaD
Sevoflurane—GRIA1—BDNF signaling pathway—AKT1—head and neck cancer	0.000224	0.00208	CbGpPWpGaD
Sevoflurane—KCNA1—Neuronal System—HRAS—head and neck cancer	0.000221	0.00206	CbGpPWpGaD
Sevoflurane—KCNK2—Neuronal System—HRAS—head and neck cancer	0.000218	0.00203	CbGpPWpGaD
Sevoflurane—KCNK3—Neuronal System—HRAS—head and neck cancer	0.000212	0.00197	CbGpPWpGaD
Sevoflurane—KCNK9—Neuronal System—HRAS—head and neck cancer	0.000212	0.00197	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—UROD—head and neck cancer	0.000202	0.00188	CbGpPWpGaD
Sevoflurane—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000201	0.00188	CbGpPWpGaD
Sevoflurane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000198	0.00185	CbGpPWpGaD
Sevoflurane—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000196	0.00183	CbGpPWpGaD
Sevoflurane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000195	0.00182	CbGpPWpGaD
Sevoflurane—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	0.000195	0.00182	CbGpPWpGaD
Sevoflurane—GRIA1—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000195	0.00181	CbGpPWpGaD
Sevoflurane—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000193	0.0018	CbGpPWpGaD
Sevoflurane—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000193	0.0018	CbGpPWpGaD
Sevoflurane—CYP2E1—Biological oxidations—GSTM1—head and neck cancer	0.000191	0.00178	CbGpPWpGaD
Sevoflurane—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000189	0.00176	CbGpPWpGaD
Sevoflurane—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000188	0.00175	CbGpPWpGaD
Sevoflurane—GRIA1—Neuronal System—MAPK1—head and neck cancer	0.000186	0.00173	CbGpPWpGaD
Sevoflurane—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	0.000185	0.00173	CbGpPWpGaD
Sevoflurane—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000185	0.00173	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—IL2—head and neck cancer	0.000185	0.00172	CbGpPWpGaD
Sevoflurane—GABRQ—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000184	0.00171	CbGpPWpGaD
Sevoflurane—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000183	0.0017	CbGpPWpGaD
Sevoflurane—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	0.000181	0.00169	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.00018	0.00168	CbGpPWpGaD
Sevoflurane—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000179	0.00167	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000177	0.00165	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—STAT3—head and neck cancer	0.00017	0.00158	CbGpPWpGaD
Sevoflurane—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000169	0.00158	CbGpPWpGaD
Sevoflurane—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000165	0.00153	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—UROD—head and neck cancer	0.000163	0.00152	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—MAPK3—head and neck cancer	0.000162	0.00151	CbGpPWpGaD
Sevoflurane—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000162	0.00151	CbGpPWpGaD
Sevoflurane—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000162	0.00151	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—UROD—head and neck cancer	0.00016	0.00149	CbGpPWpGaD
Sevoflurane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000159	0.00148	CbGpPWpGaD
Sevoflurane—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000159	0.00148	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000159	0.00148	CbGpPWpGaD
Sevoflurane—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000158	0.00148	CbGpPWpGaD
Sevoflurane—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000158	0.00147	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—TYMS—head and neck cancer	0.000156	0.00146	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—TYMS—head and neck cancer	0.000156	0.00146	CbGpPWpGaD
Sevoflurane—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000155	0.00144	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GSTM1—head and neck cancer	0.000154	0.00144	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GSTM1—head and neck cancer	0.000154	0.00144	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—MAPK1—head and neck cancer	0.000154	0.00144	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000154	0.00143	CbGpPWpGaD
Sevoflurane—GABRG3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000151	0.00141	CbGpPWpGaD
Sevoflurane—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000151	0.0014	CbGpPWpGaD
Sevoflurane—GRIA1—Neuronal System—HRAS—head and neck cancer	0.000149	0.00139	CbGpPWpGaD
Sevoflurane—GABRB1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000149	0.00139	CbGpPWpGaD
Sevoflurane—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000149	0.00139	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GPX1—head and neck cancer	0.000148	0.00138	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GPX1—head and neck cancer	0.000148	0.00138	CbGpPWpGaD
Sevoflurane—GABRQ—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000148	0.00138	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—CYP1A1—head and neck cancer	0.000146	0.00136	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—CYP1A1—head and neck cancer	0.000146	0.00136	CbGpPWpGaD
Sevoflurane—GABRA6—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000141	0.00131	CbGpPWpGaD
Sevoflurane—GABRQ—Neuronal System—MAPK1—head and neck cancer	0.000141	0.00131	CbGpPWpGaD
Sevoflurane—GABRA4—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000139	0.0013	CbGpPWpGaD
Sevoflurane—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000139	0.00129	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000138	0.00129	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—UROD—head and neck cancer	0.000137	0.00128	CbGpPWpGaD
Sevoflurane—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000136	0.00127	CbGpPWpGaD
Sevoflurane—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000135	0.00126	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—VEGFA—head and neck cancer	0.000135	0.00126	CbGpPWpGaD
Sevoflurane—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000132	0.00123	CbGpPWpGaD
Sevoflurane—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.00013	0.00121	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	0.000128	0.0012	CbGpPWpGaD
Sevoflurane—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000128	0.00119	CbGpPWpGaD
Sevoflurane—GABRB2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000127	0.00119	CbGpPWpGaD
Sevoflurane—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000127	0.00118	CbGpPWpGaD
Sevoflurane—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000124	0.00116	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—HRAS—head and neck cancer	0.000124	0.00115	CbGpPWpGaD
Sevoflurane—GABRA5—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000124	0.00115	CbGpPWpGaD
Sevoflurane—GABRA3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000121	0.00113	CbGpPWpGaD
Sevoflurane—GABRG3—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000121	0.00113	CbGpPWpGaD
Sevoflurane—GABRB1—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.00012	0.00112	CbGpPWpGaD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000119	0.00111	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TP53—head and neck cancer	0.000119	0.00111	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000119	0.00111	CbGpPWpGaD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000116	0.00109	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—MAPK1—head and neck cancer	0.000116	0.00108	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—MAPK1—head and neck cancer	0.000114	0.00106	CbGpPWpGaD
Sevoflurane—GABRA6—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000113	0.00106	CbGpPWpGaD
Sevoflurane—GABRQ—Neuronal System—HRAS—head and neck cancer	0.000113	0.00105	CbGpPWpGaD
Sevoflurane—GABRA4—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000112	0.00104	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—AKT1—head and neck cancer	0.000109	0.00102	CbGpPWpGaD
Sevoflurane—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000109	0.00101	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—MAPK1—head and neck cancer	0.000108	0.00101	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—MAPK1—head and neck cancer	0.000107	0.000995	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000106	0.000992	CbGpPWpGaD
Sevoflurane—GABRB2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000102	0.000953	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000102	0.000949	CbGpPWpGaD
Sevoflurane—GABRA5—Transmission across Chemical Synapses—HRAS—head and neck cancer	9.93e-05	0.000926	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—MAPK1—head and neck cancer	9.76e-05	0.00091	CbGpPWpGaD
Sevoflurane—GABRA3—Transmission across Chemical Synapses—HRAS—head and neck cancer	9.75e-05	0.000909	CbGpPWpGaD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—HRAS—head and neck cancer	9.59e-05	0.000894	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—HRAS—head and neck cancer	9.52e-05	0.000888	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—MAPK1—head and neck cancer	9.48e-05	0.000884	CbGpPWpGaD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—HRAS—head and neck cancer	9.35e-05	0.000872	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—MAPK1—head and neck cancer	9.31e-05	0.000868	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—HRAS—head and neck cancer	9.31e-05	0.000868	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—HRAS—head and neck cancer	9.17e-05	0.000855	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—MAPK1—head and neck cancer	9.15e-05	0.000853	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—MAPK1—head and neck cancer	9.09e-05	0.000847	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—MAPK1—head and neck cancer	8.92e-05	0.000832	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	8.88e-05	0.000828	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	8.76e-05	0.000816	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PTGS2—head and neck cancer	8.71e-05	0.000812	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PTGS2—head and neck cancer	8.71e-05	0.000812	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—HRAS—head and neck cancer	8.67e-05	0.000809	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—HRAS—head and neck cancer	8.56e-05	0.000798	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	8.42e-05	0.000785	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NAT2—head and neck cancer	8.39e-05	0.000782	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	8.3e-05	0.000774	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—HRAS—head and neck cancer	8.17e-05	0.000762	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—HRAS—head and neck cancer	7.83e-05	0.00073	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—MAPK1—head and neck cancer	7.8e-05	0.000727	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—HRAS—head and neck cancer	7.61e-05	0.000709	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PTEN—head and neck cancer	7.59e-05	0.000708	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PTEN—head and neck cancer	7.59e-05	0.000708	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—HRAS—head and neck cancer	7.47e-05	0.000697	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—UROD—head and neck cancer	7.4e-05	0.00069	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—DPYD—head and neck cancer	7.35e-05	0.000686	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—HRAS—head and neck cancer	7.34e-05	0.000685	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—HRAS—head and neck cancer	7.3e-05	0.00068	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—HRAS—head and neck cancer	7.16e-05	0.000668	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—IL2—head and neck cancer	7.03e-05	0.000656	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—YAP1—head and neck cancer	6.98e-05	0.000651	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NAT2—head and neck cancer	6.77e-05	0.000631	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NAT2—head and neck cancer	6.63e-05	0.000618	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—HRAS—head and neck cancer	6.26e-05	0.000584	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.05e-05	0.000564	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.99e-05	0.000558	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	5.98e-05	0.000557	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—DPYD—head and neck cancer	5.93e-05	0.000553	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—DPYD—head and neck cancer	5.81e-05	0.000542	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NAT2—head and neck cancer	5.7e-05	0.000531	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	5.65e-05	0.000527	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—YAP1—head and neck cancer	5.63e-05	0.000525	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—YAP1—head and neck cancer	5.51e-05	0.000514	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	5.38e-05	0.000502	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PIK3CA—head and neck cancer	5.36e-05	0.000499	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PIK3CA—head and neck cancer	5.36e-05	0.000499	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—DPYD—head and neck cancer	4.99e-05	0.000466	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—YAP1—head and neck cancer	4.74e-05	0.000442	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	4.67e-05	0.000435	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—AKT1—head and neck cancer	4.38e-05	0.000408	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—AKT1—head and neck cancer	4.38e-05	0.000408	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—TYMS—head and neck cancer	4.19e-05	0.000391	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTM1—head and neck cancer	4.14e-05	0.000386	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GPX1—head and neck cancer	3.97e-05	0.00037	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYP1A1—head and neck cancer	3.93e-05	0.000366	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	3.81e-05	0.000356	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IL2—head and neck cancer	3.63e-05	0.000338	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.56e-05	0.000332	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—TYMS—head and neck cancer	3.38e-05	0.000315	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTM1—head and neck cancer	3.34e-05	0.000312	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—TYMS—head and neck cancer	3.31e-05	0.000309	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTM1—head and neck cancer	3.27e-05	0.000305	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GPX1—head and neck cancer	3.2e-05	0.000298	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP1A1—head and neck cancer	3.17e-05	0.000295	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GPX1—head and neck cancer	3.13e-05	0.000292	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.11e-05	0.00029	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP1A1—head and neck cancer	3.1e-05	0.000289	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—VEGFA—head and neck cancer	3.08e-05	0.000287	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NAT2—head and neck cancer	3.07e-05	0.000287	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—MAPK3—head and neck cancer	2.91e-05	0.000272	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—TYMS—head and neck cancer	2.85e-05	0.000265	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTM1—head and neck cancer	2.81e-05	0.000262	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—MAPK1—head and neck cancer	2.77e-05	0.000259	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—DPYD—head and neck cancer	2.7e-05	0.000251	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GPX1—head and neck cancer	2.69e-05	0.000251	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP1A1—head and neck cancer	2.67e-05	0.000249	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—YAP1—head and neck cancer	2.56e-05	0.000239	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CA—head and neck cancer	2.41e-05	0.000224	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTGS2—head and neck cancer	2.34e-05	0.000218	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TP53—head and neck cancer	2.33e-05	0.000217	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—HRAS—head and neck cancer	2.23e-05	0.000208	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.19e-05	0.000204	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTEN—head and neck cancer	2.04e-05	0.00019	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—AKT1—head and neck cancer	1.97e-05	0.000183	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTGS2—head and neck cancer	1.88e-05	0.000176	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTGS2—head and neck cancer	1.85e-05	0.000172	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTEN—head and neck cancer	1.64e-05	0.000153	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTEN—head and neck cancer	1.61e-05	0.00015	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTGS2—head and neck cancer	1.59e-05	0.000148	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TYMS—head and neck cancer	1.54e-05	0.000143	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.52e-05	0.000142	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GPX1—head and neck cancer	1.45e-05	0.000136	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.44e-05	0.000134	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CA—head and neck cancer	1.44e-05	0.000134	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTEN—head and neck cancer	1.38e-05	0.000129	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—AKT1—head and neck cancer	1.17e-05	0.000109	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CA—head and neck cancer	1.16e-05	0.000108	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CA—head and neck cancer	1.14e-05	0.000106	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CA—head and neck cancer	9.76e-06	9.1e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—AKT1—head and neck cancer	9.47e-06	8.83e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—AKT1—head and neck cancer	9.27e-06	8.65e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTGS2—head and neck cancer	8.56e-06	7.98e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—AKT1—head and neck cancer	7.97e-06	7.43e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTEN—head and neck cancer	7.47e-06	6.96e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CA—head and neck cancer	5.27e-06	4.91e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—AKT1—head and neck cancer	4.3e-06	4.01e-05	CbGpPWpGaD
